ProQR Therapeutics NV

Most Recent

  • uploads///Graph
    Company & Industry Overviews

    ProQR Therapeutics NV Posted 153.7% Returns in the Last Month

    ProQR Therapeutics NV (PRQR) stock has risen 153.7% in the past month, from $7.35 on August 10 to $18.65 on September 10.

    By Margaret Patrick
  • uploads///Orkambi
    Earnings Report

    How Vertex Pharmaceuticals’ Drugs Performed in 1Q18

    In 1Q18, Vertex Pharmaceuticals’ (VRTX) Orkambi revenue rose ~20% YoY (year-over-year) to $354 million from $295 million.

    By Daniel Collins
  • uploads///Kalydeco
    Company & Industry Overviews

    How Did Kalydeco Perform in 4Q17 and 2017?

    In 4Q17, Vertex Pharmaceuticals’ (VRTX) Kalydeco generated revenues of $256 million, a ~45% increase on a year-over-year (or YoY) basis and 20% growth on a quarter-over-quarter (or QoQ) basis.

    By Daniel Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.